This course has expired. View available courses.
Expired
Hodgkin Lymphoma
Dr Shane Gangatharan provides an overview of Hodgkin Lymphoma, focusing on the therapies for early, advance, relapsed and refractory Hodgkin Lymphoma. This 1.5-hours module also looks at current evidence supporting therapies and describes the potential future therapeutic directions for Hodgkin Lymphoma.
DURATION
1.5 hrs
PROFESSION
Specialist
# OF CREDITS
1.5
ACCREDITATION
Certificate of Completion
EXPIRY DATE
2021-03-31
Dr Shane Gangatharan provides an overview of Hodgkin Lymphoma, focusing on the therapies for early, advance, relapsed and refractory Hodgkin Lymphoma. This 1.5-hours module also looks at current evidence supporting therapies and describes the potential future therapeutic directions for Hodgkin Lymphoma.
Faculty
Dr Shane Gangatharan
MBBS, FRACP, FRCPA
Haematologist
Fiona Stanley Hospital, Perth, WA
Senior Clinical Lecturer, University of Western Australia, Perth, WA
Learning objectives
At the end of this module, you will be better able to:
- Describe the assessment and classification of Hodgkin Lymphoma
- Define therapies for early stage and advanced stage Hodgkin Lymphoma, and for relapsed or refractory Hodgkin Lymphoma
- Explain the follow-up of Hodgkin Lymphoma and the management of late effects
- Discuss the evidence supporting therapies for Nodular Lymphocyte Predominant Hodgkin Lymphoma
- Describe potential future therapeutic directions for Hodgkin Lymphoma
Accreditation
#
of credits: 1.5
Duration: 1.5 hrs
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
Learning Objectives
At the end of this module, you will be better able to:
- Describe the assessment and classification of Hodgkin Lymphoma
- Define therapies for early stage and advanced stage Hodgkin Lymphoma, and for relapsed or refractory Hodgkin Lymphoma
- Explain the follow-up of Hodgkin Lymphoma and the management of late effects
- Discuss the evidence supporting therapies for Nodular Lymphocyte Predominant Hodgkin Lymphoma
- Describe potential future therapeutic directions for Hodgkin Lymphoma
Certificate of Completion
ACCREDITATION
Expired
Learning Category
General
Topic
0
Price
2021-03-31
Expiry Date
AUS
Region/Language
Course Description
Dr Shane Gangatharan provides an overview of Hodgkin Lymphoma, focusing on the therapies for early, advance, relapsed and refractory Hodgkin Lymphoma. This 1.5-hours module also looks at current evidence supporting therapies and describes the potential future therapeutic directions for Hodgkin Lymphoma.
Faculty
Dr Shane Gangatharan
MBBS, FRACP, FRCPA
Haematologist
Fiona Stanley Hospital, Perth, WA
Senior Clinical Lecturer, University of Western Australia, Perth, WA
Accreditation
The curriculum is endorsed by the RACP/RCPA Committee for Joint College training in Haematology (CJCT) and the Haematology Society of Australia and New Zealand (HSANZ). Fellows of the RACP may claim CPD hours under the CPD Program (CPDP).
1.5 hrs
Duration
0
Price
1.5
# of credits
